Safety Study of Fenofibrate During Pregnancy
NCT05883865 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2023-06-01
Summary
The purpose of this study is to evaluate the safety of fenofibrate in severe hypertriglyceridemia pregnant women.
Conditions
- Severe Hypertriglyceridemia During Pregnancy
Interventions
- DRUG
-
Fenofibrate
Fenofibrate is orally administrated daily with food for at least 1 week during pregnancy
Sponsors & Collaborators
-
First People's Hospital of Hangzhou
lead OTHER
Eligibility
- Min Age
- 20 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-06-01
- Primary Completion
- 2024-06-01
- Completion
- 2025-12-01
- FDA Drug
- Yes
Countries
- China
Study Locations
More Related Trials
-
Lipid Profile as Predictor of Adverse Maternal and Neonatal Outcomes: A Pilot Study
NCT05535660 ·Status: COMPLETED
-
Iron Deficiency Anemia in Twin Pregnancies
NCT04975074 ·Status: UNKNOWN ·Phase: PHASE4
-
Bempedoic Acid Pregnancy Surveillance Program
NCT05103254 ·Status: RECRUITING
-
Maternal and Fetal Outcomes in Pregnant Women With COVID -19,a Cross Sectional Study
NCT05608616 ·Status: COMPLETED
-
Effects of Retinoids on CYP2D6 Activity During Pregnancy
NCT03117660 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Effectiveness of First Trimester Pre-eclampsia Screening Program.
NCT04021680 ·Status: UNKNOWN
-
Angiogenic Factors in the Conservative Management of Gestational Hypertension
NCT06123377 ·Status: RECRUITING ·Phase: NA
-
Cohort of Twin Pregnancy and the Offspring
NCT05727085 ·Status: RECRUITING
-
Metformin to Prevent Preterm Birth in Twin Pregnancy
NCT05412056 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring
NCT05739123 ·Status: RECRUITING
-
Evolocumab Pregnancy Exposure Registry
NCT02957604 ·Status: TERMINATED
-
Effects of COVID-19 Infection on Pregnancy Outcomes and Offspring Health
NCT06186947 ·Status: RECRUITING
-
A Study to Describe Mothers' and Babies' Outcomes After Exposure to HyQvia During Pregnancy
NCT05803200 ·Status: COMPLETED
-
Median Study for Biochemical Serum Markers in First Trimester of Pregnancy
NCT01891370 ·Status: COMPLETED
-
Serum Kisspeptin: a Predictive Marker of Miscarriage or Not?
NCT03940495 ·Status: COMPLETED
-
Neutrophil Extracellular Traps Mediate Antiphospholipid Antibody-induced Pregnancy Loss
NCT03735108 ·Status: UNKNOWN
-
Metformin for Preeclampsia Prevention in Pregnant Women With Type 1 Diabetes Mellitus
NCT03570632 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Clinical Follow-up of Pregnant Subjects Undergoing NIPT
NCT04595201 ·Status: RECRUITING
-
RCT on the Efficacy of Methotrexate for the Prevention of GTD
NCT01984099 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Mediterranean Diet During Pregnancy on the Onset of Overweight and Obesity in the Offspring
NCT03337802 ·Status: COMPLETED ·Phase: NA
-
Exenatide Pregnancy Registry - Type 2 Diabetes in Pregnancy
NCT00579150 ·Status: TERMINATED
-
Organization of Teratology Information Services (OTIS) Autoimmune Diseases in Pregnancy Project
NCT00116272 ·Status: COMPLETED
-
The Effect of Iron Deficiency Anemia During Pregnancy
NCT02590224 ·Status: COMPLETED ·Phase: PHASE4
-
Fibroblast Growth Factor 23 and Hypertensive Disorder Complicating Pregnancy
NCT03821922 ·Status: UNKNOWN
-
The Oral Iron on the Prevention of Iron Deficiency Anemia in Obese Pregnant
NCT04101461 ·Status: COMPLETED ·Phase: NA